Global Alliance against Chronic Respiratory Diseases

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 62, Issue 3, 2007, Pages 216-223

  Bousquet, J ^a   Dahl, R ^b   Khaltaev, N ^c  

^a HÔPITAL ARNAUD DE VILLENEUVE   (France)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Asthma; Chronic obstructive pulmonary disease; Chronic respiratory diseases; World Health Organization

Indexed keywords

CHRONIC DISEASE; CHRONIC RESPIRATORY TRACT DISEASE; DEVELOPING COUNTRY; HEALTH CARE ORGANIZATION; HEALTH CARE PLANNING; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HEALTH SERVICE; HUMAN; HUMAN NEEDS; INSTITUTIONAL CARE; PREVENTION AND CONTROL; PRIORITY JOURNAL; REVIEW; RISK FACTOR; WORLD HEALTH ORGANIZATION;

EID: 33846991952     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2007.01307.x     Document Type: Review

References (43)

1. World Health Organization. Preventing chronic diseases: a vital investment. WHO global report, 2005. http://www.who.int/chp/ chronic_disease_report/full_report.pdf. Date last accessed: December 2006.
2. Strong K, Mathers C, Leeder S, Beaglehole R. Preventing chronic diseases: how many lives can we save? Lancet 2005;366:1578-1582.
3. Lee J. Global health improvement and WHO: shaping the future. Lancet 2003;362:2083-2088.
4. Srinath Reddy K, Shah B, Varghese C, Ramadoss A. Responding to the threat of chronic diseases in India. Lancet 2005;366:1744-1749.
5. Wang L, Kong L, Wu F, Bai Y, Burton R. Preventing chronic diseases in China. Lancet 2005;366:1821-1824.
6. World Health Organization. International Statistical Classification of Diseases and Related Health Problems. 10th Revision Version for 2003. Geneva: World Health Organization Press, 2003.
7. Masoli M, Fabian D, Holt S, Beasley R. The Global Initiative for Asthma (GINA) Program. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy 2004;59:469-478.
8. The World Health Organization. Preventing risks and taking action. In: The World Health Report. Geneva: World Health Organization Press, 2002: p. 167.
9. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. Lancet 1998;351:1225-1232.
10. Janson C, Anto J, Burney P et al. The European Community Respiratory Health Survey: what are the main results so far? European Community Respiratory Health Survey II. Eur Respir J 2001;18:598-611.
11. Bauchau V, Durham SR. Epidemiological characterization of the intermittent and persistent types of allergic rhinitis. Allergy 2005;60:350-353.
12. Bauchau V, Durham SR. Prevalence and rate of diagnosis of allergic rhinitis in Europe. Eur Respir J 2004; 24: 758-764.
13. Pearce N, Sunyer J, Cheng S et al. Comparison of asthma prevalence in the ISAAC and the ECRHS. ISAAC Steering Committee and the European Community Respiratory Health Survey. International Study of Asthma and Allergies in Childhood. Eur Respir J 2000;16:420-426.
14. Ross MH, Murray J. Occupational respiratory disease in mining. Occup Med (Lond) 2004;54:304-310.
15. Wang XR, Christiani DC. Occupational lung disease in China. Int J Occup Environ Health 2003;9:320-325.
16. Barbosa MM, Lamounier JA, Oliveira EC et al. Pulmonary hypertension in schistosomiasis mansoni. Trans R Soc Trop Med Hyg 1996;90:663-665.
17. Powars DR, Chan LS, Hiti A, Ramicone E, Johnson C. Outcome of sickle cell anemia: a 4-decade observational study of 1056 patients. Medicine (Baltimore) 2005;84:363-376.
18. Machado RF, Gladwin MT. Chronic sickle cell lung disease: new insights into the diagnosis, pathogenesis and treatment of pulmonary hypertension. Br J Haematol 2005;129:449-464.
19. Aldashev AA, Sarybaev AS, Sydykov AS et al. Characterization of high-altitude pulmonary hypertension in the Kyrgyz: association with angiotensin-converting enzyme genotype. Am J Respir Crit Care Med 2002;166:1396-1402.
20. Ge RL, Helun G. Current concept of chronic mountain sickness: pulmonary hypertension-related high-altitude heart disease. Wilderness Environ Med 2001;12:190-194.
21. Gislason T, Almqvist M, Eriksson G, Taube A, Boman G. Prevalence of sleep apnea syndrome among Swedish men an epidemiological study. J Clin Epidemiol 1988;41:571-576.
22. Enright PL, Newman AB, Wahl PW, Manolio TA, Haponik EF, Boyle PJ. Prevalence and correlates of snoring and observed apneas in 5,201 older adults. Sleep 1996;19:531-538.
23. Ohayon MM, Guilleminault C, Priest RG, Caulet M. Snoring and breathing pauses during sleep: telephone interview survey of a United Kingdom population sample. BMJ 1997;314:860-863.
24. Larsson LG, Lindberg A, Franklin KA, Lundback B. Gender differences in symptoms related to sleep apnea in a general population and in relation to referral to sleep clinic. Chest 2003;124:204-211.
25. Haahtela T, Tuomisto LE, Pietinalho A et al. A 10 year asthma programme in Finland: major change for the better. Thorax 2006;61:663-670.
26. Fairall LR, Zwarenstein M, Bateman ED et al. Effect of educational outreach to nurses on tuberculosis case detection and primary care of respiratory illness: pragmatic cluster randomised controlled trial. BMJ 2005;331:750-754.
27. Fischer GB, Camargos PA, Mocelin HT. The burden of asthma in children: a Latin American perspective. Paediatr Respir Rev 2005;6:8-13.
28. Evans R III, Gergen PJ, Mitchell H et al. A randomized clinical trial to reduce asthma morbidity among inner-city children: results of the National Cooperative Inner-City Asthma Study. J Pediatr 1999;135:332-338.
29. Cloutier MM, Hall CB, Wakefield DB, Bailit H. Use of asthma guidelines by primary care providers to reduce hospitalizations and emergency department visits in poor, minority, urban children. J Pediatr 2005;146:591-597.
30. Ezzati M, Lopez AD. Estimates of global mortality attributable to smoking in 2000. Lancet 2003;362:847-852.
31. Janson C. The effect of passive smoking on respiratory health in children and adults. Int J Tuberc Lung Dis 2004;8:510-516.
32. Bruce N, Perez-Padilla R, Albalak R. Indoor air pollution in developing countries: a major environmental and public health challenge. Bull World Health Organ 2000;78:1078-1092.
33. American Thoracic Society. What constitutes an adverse health effect of air pollution? Official statement of the American Thoracic Society. Am J Respir Crit Care Med 2000;161:665-673.
34. Balmes J, Becklake M, Blanc P et al. American Thoracic Society Statement: occupational contribution to the burden of airway disease. Am J Respir Crit Care Med 2003;167:787-797.
35. Khaltaev N. WHO strategy for prevention and control of chronic obstructive pulmonary disease. Exp Lung Res 2005;31(Suppl. 1):55-56.
36. World Health Organization. WHO strategy for prevention and control of chronic respiratory diseases. World Health Organization Publications, 2001. http://www.who.int/respiratory/publications/WHO_MNC_CRA_02.1.pdf. Date last accessed: December 2006.
37. World Health Organization. Implementation of the WHO strategy for prevention and control of chronic respiratory diseases. Geneva: World Health Organization meeting report, 2002. http://www.who.int/respiratory/publications/ WHO_MNC_CRA_02.2.pdf. Date last accessed: December 2006.
38. World Health Organization. Prevention and control of chronic respiratory diseases in low and middle-income African countries: a preliminary report. Geneva: World Health Organization meeting report, 2004.
39. World Health Organization. Prevention and control of chronic respiratory diseases at country level: towards a Global Alliance against Chronic Respiratory Diseases. Geneva: World Health Organization meeting report, 2005. http://www.who.int/respiratory/publications/WHO_NMH_CHP_CPM_CRA_05.1.pdf. Date last accessed: December 2006.
40. Epping-Jordan JE, Galea G, Tukuitonga C, Beaglehole R. Preventing chronic diseases: taking stepwise action. Lancet 2005;366:1667-1671.
41. Haahtela T, Klaukka T, Koskela K, Erhola M, Laitinen LA. Asthma programme in Finland: a community problem needs community solutions. Thorax 2001;56:806-814.
42. ten Asbroek AH, Delnoij DM, Niessen LW et al. Implementing global knowledge in local practice: a WHO lung health initiative in Nepal. Health Policy Plan 2005;20:290-301.
43. Billo NE. Do we need an asthma drug facility? Int J Tuberc Lung Dis 2004;8:391.